STMN1 and hepatocellular carcinoma: As shown in Figure 1A, only 2 of 372 (0.54%) and 1 of 372 (0.27%) HCC patients harbored STMN1 gene mutation and deep deletion, respectively, in the TCGA-LIHC dataset, and no alteration was found in the other five datasets.